देश में एक बार फिर Covid के मामलों में इजाफा देखने को मिल रहा है.
एक्टिव केस 1000 के पर निकल गया है. वहीं, यूएस प्रेसिडेंट डोनाल्ड ट्रंप
फार्मा सेक्टर पर 25% टैरिफ लगाने वाले हैं. खासकर जेनरिक मेडिसिन सेक्टर इससे प्रभावित होगी. देश में तेजी से बढ़ती जेनरिक मेडिसिन इंडस्ट्री की दिग्गज प्राइवेट प्लेयर दवाइंडिया के मैनेजमेंट से गुड़रिटर्न्स ने बातचीत
की. दवाइंडिया की पैरेंट कंपनी जोटा हेल्थकेयर के ग्रुप सीईओ डॉ. सुजीत पॉल से रूरल एरिया में जेनरिक मेडिसिन की पहुंच समेत ग्लोबल एक्सपेंशन पर चर्चा हुई.
#coronavirus #coronacasesrise #davaindia #genericpharmacy #sujitpaul #coronanews #coronavaccine #covid19 #covid19newsupdate #pharmacyindia
एक्टिव केस 1000 के पर निकल गया है. वहीं, यूएस प्रेसिडेंट डोनाल्ड ट्रंप
फार्मा सेक्टर पर 25% टैरिफ लगाने वाले हैं. खासकर जेनरिक मेडिसिन सेक्टर इससे प्रभावित होगी. देश में तेजी से बढ़ती जेनरिक मेडिसिन इंडस्ट्री की दिग्गज प्राइवेट प्लेयर दवाइंडिया के मैनेजमेंट से गुड़रिटर्न्स ने बातचीत
की. दवाइंडिया की पैरेंट कंपनी जोटा हेल्थकेयर के ग्रुप सीईओ डॉ. सुजीत पॉल से रूरल एरिया में जेनरिक मेडिसिन की पहुंच समेत ग्लोबल एक्सपेंशन पर चर्चा हुई.
#coronavirus #coronacasesrise #davaindia #genericpharmacy #sujitpaul #coronanews #coronavaccine #covid19 #covid19newsupdate #pharmacyindia
Category
🗞
NewsTranscript
00:00Namaskar, my name is Dighbhijay Singh, Good Returns, welcome to Jota Healthcare Group CEO, Dr. Sujit Paul Ji.
00:08Sir, welcome to Good Returns.
00:10First question, sir, generic medicine that is growing in India.
00:14How does your consumers trust?
00:17What do you want to say about generic medicine?
00:21Our consumers know that for Dawa India, these are always very high quality generic medicines.
00:28And whenever they consume these medicines, they know that they are getting healthier and fitter much faster.
00:34So they are very confident on our quality always.
00:37So in urban areas, trust and awareness, consumers are going to buy stores.
00:44What are the demand for generic medicines in rural areas?
00:48In rural areas, the demand has already started.
00:51We are doing a lot of work in rural areas.
00:53We are working with gram panchayat.
00:55We are working with gram panchayat.
00:57We are working in the interiors of villages to make people understand the utility of high quality generic medicines.
01:03How many new steps are you utilizing in pharma distribution?
01:07Especially in terms of AI.
01:09Are you utilizing it in your distribution activity?
01:12We have initiated AI and blockchain to utilize it so that if you have to have a patient somewhere where they are consuming the generic medicines, then in a moment the medicines are getting finished, then the refills can go through automatically as a trigger.
01:28There are multiple activities that we have initiated through AI, but it's a work in progress always.
01:32Now, when I look at the pre-COVID numbers in your stores, they are double digits in 79, 78, and 2019.
01:40After the COVID pandemic, the numbers are 200 plus.
01:46Now, we are currently around 1,600.
01:50What is your aim for?
01:51How many expenses are you doing in India?
01:55If I talk about the global expenses.
01:58So, for India, we are growing phenomenally faster.
02:02Because our only objective is that across India, we must ensure that everyone can get high quality generic medicines.
02:11So, we are growing exponentially faster in India.
02:13And we would be continuing to spread in the same way to ensure that we make India much more healthy at the earliest.
02:20Now, the tension of COVID is increasing.
02:23The numbers are actively increasing around the world.
02:26In India, there are also 1,000 cases.
02:30How many concerns are we now?
02:33Are we ready for it?
02:34And how many risks are we rolling in the general medicine?
02:37I personally feel that, you know, India is always ready for this.
02:41We are always ready for this.
02:42We are always ready for this.
02:43We are always ready for this.
02:44And we will be ready for this.
02:45And the most important thing is that, this COVID strain, people should not really panic so much.
02:50It's only that, you know, we have to ensure enough amount of protections.
02:53We have to ensure masks.
02:55Otherwise, I think India, as I have told you, is ready for this.
02:59And that, we will be ready for this.
03:02We will always be ready for this.
03:03If you are concerned about the pharmaceutical sector, especially pharma,
03:06the US Tariff has proposed, the US Tariff under President Trump.
03:1025% Tariff under the pharmaceutical sector.
03:14When you are in generic medicines, what kind of impact do you see?
03:19Especially you, or for industry?
03:20I don't foresee too much of impact because by the way our government of India is working we are always in a foolproof situation under the leadership of our honorable prime minister.
03:32The fantastic leadership actually is driving to ensure that India is always protected and there is nothing to worry for any one of us in India.
03:40The current government has a big role in it. The current government has launched a lot of schemes.
03:50You are also actively working with private players. How has the impact on the government of the initiative?
03:58I think the government is working in this country. This is the best government that we have actually seen.
04:05The way the government is working is phenomenal. And the way the government is pushing their stores.
04:12We are also trying to do it from the private level. Because the objective is that the country should be more healthy.
04:19So the government is trying the best from their perspective. We are trying from our perspective.
04:23Because both of us have the same idea that India should be much more healthy and that's what we are doing.
04:28In the primary market, I am talking about the market. You are actively in this time the media appearance is very big.
04:32What is your plan that you are growing and growing? What is your plan that you are growing and growing?
04:37What is your plan that you are looking for in the market?
04:39In the market, you are looking for listing or IPO. What is your plan?
04:43I think it is more important for us to understand what our prime plan is.
04:48Our prime plan is that we will all work together to build a better India on a healthcare segment at large.
04:54Thank you so much sir. Thank you very much for your precious time.